Related Experiment Video

Updated: Jun 24, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Growth inhibition by tyrosine kinase inhibitors in mesothelioma cell lines

Joyce E Nutt1, Kieran O'Toole, David Gonzalez

  • 1Northern Institute for Cancer Research, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. J.E.Nutt@ncl.ac.uk

European Journal of Cancer (Oxford, England : 1990)
|March 26, 2009
PubMed

Insights

Tyrosine kinase inhibitors targeting VEGFR2 show promise for treating malignant pleural mesothelioma. These drugs effectively inhibited cancer cell growth and key signaling pathways in preclinical models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Malignant pleural mesothelioma has a poor clinical outcome with current chemotherapy.
  • Novel therapeutic strategies are urgently needed to improve patient survival.
  • Tyrosine kinase inhibitors (TKIs) represent a potential targeted therapy approach.

Purpose of the Study:

  • To evaluate the efficacy of five TKIs (PTK787, ZD6474, ZD1839, SU6668, SU11248) against mesothelioma cell lines.
  • To assess the expression of growth factor receptors (EGFR, VEGFR2) and downstream signaling.
  • To determine the inhibitory effects of TKIs on cancer cell proliferation and signaling pathways.

Main Methods:

  • Assessed the growth inhibitory concentration 50 (GI50) of five TKIs across three mesothelioma cell lines (NCI H226, NCI H28, MSTO 211H).
  • Utilized Western blotting to detect EGFR and VEGFR2 expression.
  • Investigated the inhibition of EGF- and VEGF-induced phosphorylation of downstream signaling molecules (EGFR, AKT, ERK, VEGFR2).
  • Confirmed VEGFR2 expression in tumor samples via immunohistochemistry.

Main Results:

  • ZD6474 and SU11248 (VEGFR2 inhibitors) demonstrated the lowest GI50 values across all cell lines (3.5-6.9 microM).
  • All cell lines expressed EGFR; only H226 cells showed VEGFR2 expression by Western blot.
  • ZD6474 and ZD1839 inhibited EGF-induced signaling, while SU11248 potently inhibited VEGF-induced VEGFR2 phosphorylation.
  • VEGFR2 was confirmed in mesothelioma tumor samples.

Conclusions:

  • VEGFR2 tyrosine kinase inhibitors exhibit significant preclinical activity against mesothelioma.
  • Targeting VEGFR2 signaling warrants further clinical investigation for malignant pleural mesothelioma treatment.

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...